193 related articles for article (PubMed ID: 34458738)
1. Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment.
Neumann WL; Sandoval KE; Mobayen S; Minaeian M; Kukielski SG; Srabony KN; Frare R; Slater O; Farr SA; Niehoff ML; Hospital A; Kontoyianni M; Crider AM; Witt KA
RSC Med Chem; 2021 Aug; 12(8):1352-1365. PubMed ID: 34458738
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a 3,4,5-trisubstituted-1,2,4-triazole agonist with high affinity and selectivity at the somatostatin subtype-4 (sst
Daryaei I; Sandoval K; Witt K; Kontoyianni M; Michael Crider A
Medchemcomm; 2018 Dec; 9(12):2083-2090. PubMed ID: 30746066
[TBL] [Abstract][Full Text] [Related]
3. Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice.
Sandoval KE; Farr SA; Banks WA; Niehoff ML; Morley JE; Crider AM; Witt KA
Eur J Pharmacol; 2011 Mar; 654(1):53-9. PubMed ID: 21185826
[TBL] [Abstract][Full Text] [Related]
4. Small molecule somatostatin receptor subtype 4 (sst
Szőke É; Bálint M; Hetényi C; Markovics A; Elekes K; Pozsgai G; Szűts T; Kéri G; Őrfi L; Sándor Z; Szolcsányi J; Pintér E; Helyes Z
Neuropharmacology; 2020 Nov; 178():108198. PubMed ID: 32739276
[TBL] [Abstract][Full Text] [Related]
5. Nonpeptide somatostatin agonists with sst4 selectivity: synthesis and structure-activity relationships of thioureas.
Liu S; Tang C; Ho B; Ankersen M; Stidsen CE; Crider AM
J Med Chem; 1998 Nov; 41(24):4693-705. PubMed ID: 9822540
[TBL] [Abstract][Full Text] [Related]
6. 2-pyridylthioureas: novel nonpeptide somatostatin agonists with SST4 selectivity.
Liu S; Crider AM; Tang C; Ho B; Ankersen M; Stidsen CE
Curr Pharm Des; 1999 Apr; 5(4):255-63. PubMed ID: 10101224
[TBL] [Abstract][Full Text] [Related]
7. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
Atack JR
Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171
[TBL] [Abstract][Full Text] [Related]
8. Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain.
Kántás B; Börzsei R; Szőke É; Bánhegyi P; Horváth Á; Hunyady Á; Borbély É; Hetényi C; Pintér E; Helyes Z
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835716
[TBL] [Abstract][Full Text] [Related]
9.
Kántás B; Szőke É; Börzsei R; Bánhegyi P; Asghar J; Hudhud L; Steib A; Hunyady Á; Horváth Á; Kecskés A; Borbély É; Hetényi C; Pethő G; Pintér E; Helyes Z
Front Pharmacol; 2020; 11():601887. PubMed ID: 33815096
[No Abstract] [Full Text] [Related]
10. Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity.
Moltzen EK; Pedersen H; Bøgesø KP; Meier E; Frederiksen K; Sánchez C; Løve Lembøl H
J Med Chem; 1994 Nov; 37(24):4085-99. PubMed ID: 7990109
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin sst4 ligands: chemistry and pharmacology.
Crider AM; Witt KA
Mini Rev Med Chem; 2007 Mar; 7(3):213-20. PubMed ID: 17346214
[TBL] [Abstract][Full Text] [Related]
12. Expression changes of somatostatin receptor subtypes sst2A, sst2B, sst3 and sst4 after a cortical contusion trauma in rats.
Braun H; Schulz S; Höllt V
Brain Res; 2002 Mar; 930(1-2):191-9. PubMed ID: 11879809
[TBL] [Abstract][Full Text] [Related]
13. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL
J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873
[TBL] [Abstract][Full Text] [Related]
14. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
[TBL] [Abstract][Full Text] [Related]
15. A structure-based approach to understanding somatostatin receptor-4 agonism (sst4).
Liu Z; Crider AM; Ansbro D; Hayes C; Kontoyianni M
J Chem Inf Model; 2012 Jan; 52(1):171-86. PubMed ID: 22148589
[TBL] [Abstract][Full Text] [Related]
16. Differential efficacies of somatostatin receptor agonists for G-protein activation and desensitization of somatostatin receptor subtype 4-mediated responses.
Engström M; Savola JM; Wurster S
J Pharmacol Exp Ther; 2006 Mar; 316(3):1262-8. PubMed ID: 16291731
[TBL] [Abstract][Full Text] [Related]
17. Potent antagonists of somatostatin: synthesis and biology.
Hocart SJ; Jain R; Murphy WA; Taylor JE; Morgan B; Coy DH
J Med Chem; 1998 Mar; 41(7):1146-54. PubMed ID: 9544214
[TBL] [Abstract][Full Text] [Related]
18. Highly potent cyclic disulfide antagonists of somatostatin.
Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
[TBL] [Abstract][Full Text] [Related]
19. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Neurons Expressing the Novel Analgesic Drug Target Somatostatin Receptor 4 in Mouse and Human Brains.
Kecskés A; Pohóczky K; Kecskés M; Varga ZV; Kormos V; Szőke É; Henn-Mike N; Fehér M; Kun J; Gyenesei A; Renner É; Palkovits M; Ferdinandy P; Ábrahám IM; Gaszner B; Helyes Z
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
